Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Bibliography

Falck, J., Lukas, C., Protopopova, M., Lukas, J., Selivanova, G., & Bartek, J. (2001). Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene, 20(39), 5503–5510.

Authors 6
  1. Jacob Falck (first)
  2. Claudia Lukas (additional)
  3. Marina Protopopova (additional)
  4. Jiri Lukas (additional)
  5. Galina Selivanova (additional)
  6. Jiri Bartek (additional)
References 31 Referenced 92
  1. Albrechtsen N, Dornreiter I, Grosse F, Kim E, Wiesmuller L, Deppert W . 1999 Oncogene 18: 7706–7717 (10.1038/sj.onc.1202952)
  2. Bartek J, Iggo R, Gannon J, Lane DP . 1990 Oncogene 5: 893–899
  3. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA . 1999 Science 286: 2528–2531 (10.1126/science.286.5449.2528)
  4. Carr AM . 2000 Science 287: 1765–1766 (10.1126/science.287.5459.1765)
  5. Caspari T . 2000 Curr. Biol. 10: R315–R317 (10.1016/S0960-9822(00)00439-5)
  6. Chehab NH, Malikzay A, Appel M, Halazonetis TD . 2000 Genes Dev. 14: 278–288 (10.1101/gad.14.3.278)
  7. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD . 1999 Proc. Natl. Acad. Sci. USA 96: 13777–13782 (10.1073/pnas.96.24.13777)
  8. Durocher D, Henckel J, Fersht AR, Jackson SP . 1999 Mol. Cell. 4: 387–394 (10.1016/S1097-2765(00)80340-8)
  9. Falck J, Mailand N, Syljuåsen RG, Bartek J, Lukas J . 2001 Nature 410: 842–847 (10.1038/35071124)
  10. Giaccia AJ, Kastan MB . 1998 Genes Dev. 12: 2973–2983 (10.1101/gad.12.19.2973)
  11. Gire V, Wynford-Thomas D . 1998 Mol. Cell. Biol. 18: 1611–1621 (10.1128/MCB.18.3.1611)
  12. Haruki N, Saito H, Tatematsu Y, Konishi H, Harano T, Masuda A, Osada H, Fujii Y, Takahashi T . 2000 Cancer Res. 60: 4689–4692
  13. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW . 2000 Science 287: 1824–1827 (10.1126/science.287.5459.1824)
  14. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, Kastan MB . 2000 Nature 404: 613–617 (10.1038/35007091)
  15. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J . 1997 Genes Dev. 11: 1479–1492 (10.1101/gad.11.11.1479)
  16. Mailand N, Falck J, Lukas C, Syljuåsen RG, Welcker M, Bartek J, Lukas J . 2000 Science 288: 1425–1429 (10.1126/science.288.5470.1425)
  17. Matsuoka S, Huang M, Elledge SJ . 1998 Science 282: 1893–1897 (10.1126/science.282.5395.1893)
  18. Meek DW . 2000 Pathol. Biol. (Paris) 48: 246–254 (10.1067/mno.2000.109818)
  19. Melchionna R, Chen X-B, Blasina A, McGowan CH . 2000 Nat. Cell. Biol. 2: 762–765 (10.1038/35036406)
  20. O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace Jr AJ, Kohn KW . 1997 Cancer Res. 57: 4285–4300
  21. Petrini JH . 2000 Nat. Genet. 26: 257–258 (10.1038/81529)
  22. Rotman G, Shiloh Y . 1999 Oncogene 18: 6135–6144 (10.1038/sj.onc.1203124)
  23. Santoni-Rugiu E, Falck J, Mailand N, Bartek J, Lukas J . 2000 Mol. Cell. Biol. 20: 3497–3509 (10.1128/MCB.20.10.3497-3509.2000)
  24. Selivanova G, Iotsova V, Kiseleva E, Steinbeck M, Bakalkin G, Grafström RC, Wiman KG . 1996 Nucleic Acids Res. 24: 3560–3567 (10.1093/nar/24.18.3560)
  25. Shaulian E, Zauberman A, Ginsberg D, Oren M . 1992 Mol. Cell. Biol. 12: 5581–5592 (10.1128/MCB.12.12.5581)
  26. Sherr CJ . 1998 Genes Dev. 12: 2984–2991 (10.1101/gad.12.19.2984)
  27. Shieh S-Y, Ahn J, Tamai K, Taya Y, Prives C . 2000 Genes Dev. 14: 289–300 (10.1101/gad.14.3.289)
  28. Sturzbecher HW, Brain R, Addison C, Rudge K, Remm M, Grimaldi M, Keenan E, Jenkins JR . 1992 Oncogene 7: 1513–1523
  29. Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310 (10.1038/35042675)
  30. Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA . 1998 Oncogene 16: 721–736 (10.1038/sj.onc.1201793)
  31. Zhou BB, Elledge SJ . 2000 Nature 408: 433–439 (10.1038/35044005)
Dates
Type When
Created 22 years, 11 months ago (Sept. 20, 2002, 2:53 p.m.)
Deposited 3 years, 5 months ago (March 21, 2022, 8:46 p.m.)
Indexed 11 months, 2 weeks ago (Sept. 15, 2024, 4:29 a.m.)
Issued 23 years, 11 months ago (Sept. 6, 2001)
Published 23 years, 11 months ago (Sept. 6, 2001)
Published Online 23 years, 11 months ago (Sept. 12, 2001)
Published Print 23 years, 11 months ago (Sept. 6, 2001)
Funders 0

None

@article{Falck_2001, title={Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway}, volume={20}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1204811}, DOI={10.1038/sj.onc.1204811}, number={39}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Falck, Jacob and Lukas, Claudia and Protopopova, Marina and Lukas, Jiri and Selivanova, Galina and Bartek, Jiri}, year={2001}, month=sep, pages={5503–5510} }